Ethane

Ethane

SCHEMBL3667087

CC.Cc1ccc(N2CCN(C(=O)C(C)(C)CN3CCNCC3)CC2)cc1

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB1 P08588 1/20 0.50
AKR1C3 P42330 1/20 0.45
MAPT P10636 4/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
LMNA P02545 2/20 0.44
GAA P10253 2/20 0.44
ALDH1A1 P00352 2/20 0.44
KDM4E B2RXH2 1/20 0.44
ALOX15 P16050 1/20 0.44
ALOX12 P18054 1/20 0.44
GFER P55789 1/20 0.44
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
CYP2C19 P33261 2/20 0.43
POLB P06746 1/20 0.42
GPR119 Q8TDV5 1/20 0.42
HTT P42858 1/20 0.42
ESRRB O95718 2/20 0.41
ESRRG P62508 2/20 0.41
ENPP2 Q13822 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methane SCHEMBL3666926 0.98 ADRB1 (0.50) ADRB1AKR1C3MAPTSMN1; SMN2LMNA
Methane SCHEMBL3668794 0.87 LMNA (0.49) ADRB1AKR1C3MAPTSMN1; SMN2LMNA
SCHEMBL314459 0.85 NPC1 (0.48) AKR1C3MAPTSMN1; SMN2LMNAGAA
SCHEMBL314179 0.85 AKR1C3 (0.47) AKR1C3MAPTSMN1; SMN2LMNAGAA
SCHEMBL12788651 0.75 AKR1C3 (0.59) AKR1C3MAPTSMN1; SMN2LMNAGAA
SCHEMBL23544885 0.74 AKR1C3 (0.58) AKR1C3MAPTSMN1; SMN2LMNAGAA
SCHEMBL315629 0.74 DRD4 (0.53) MAPTSMN1; SMN2LMNAGAAALDH1A1
SCHEMBL315213 0.74 SMN1; SMN2 (0.56) AKR1C3MAPTSMN1; SMN2LMNAGAA
SCHEMBL314363 0.73 HTR7 (0.53) MAPTLMNAALDH1A1MEN1KMT2A
Bicarbonate SCHEMBL11620170 0.72 ADRB1 (0.81) ADRB1AKR1C3MAPTLMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2234992-A2 PIPERAZINE DERIVATIVES AND THEIR USE AS LEPTIN RECEPTOR MODULATORS AstraZeneca AB (SE) 2010-10-06 EP claimed
WO-2009071668-A2 PIPERAZINE DERIVATIVES AND THEIR USE AS LEPTIN RECEPTOR MODULATORS BIOVITRUM AB (PUBL) (SE) 2009-06-11 WO claimed